8-K - Acrivon Therapeutics, Inc. Common Stock | StockGist

Current Report Details

Event Type

Material Agreement

Disclosure

Mandatory

Variant

8-K

Items Reported

1.02

Termination of Material Definitive Agreement On February 18, 2026, Acrivon Therapeutics, Inc. (the “Company”) announced the completion and certification of its

Material Agreement

Exhibits (1)

8-K